Cognitive Effects of Cancer and Cancer Treatments
- 18 January 2018
- journal article
- research article
- Published by Annual Reviews in Annual Review of Clinical Psychology
- Vol. 14 (1), 425-451
- https://doi.org/10.1146/annurev-clinpsy-050817-084903
Abstract
As the population of cancer survivors has grown into the millions, there has been increasing emphasis on understanding how the late effects of treatment affect survivors’ ability to return to work/school, their capacity to function and live independently, and their overall quality of life. This review focuses on cognitive change associated with cancer and cancer treatments. Research in this area has progressed from a pharmacotoxicology perspective to a view of the cognitive change as a complex interaction of aspects of the treatment, vulnerability factors that increase risk for posttreatment cognitive decline, cancer biology, and the biology of aging. Methodological advances include the development of (a) measurement approaches that assess more fine-grained subcomponents of cognition based on cognitive neuroscience and (b) advanced statistical approaches. Conceptual issues that arise from this multidimensional perspective are described in relation to future directions, understanding of mechanisms, and development of innovative interventions. Expected final online publication date for the Annual Review of Clinical Psychology Volume 14 is May 7, 2018. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.Keywords
This publication has 149 references indexed in Scilit:
- Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivorsBrain, Behavior, and Immunity, 2013
- Cellular senescence: A link between cancer and age-related degenerative disease?Seminars in Cancer Biology, 2011
- Psychostimulants as Cognitive Enhancers: The Prefrontal Cortex, Catecholamines, and Attention-Deficit/Hyperactivity DisorderBiological Psychiatry, 2011
- Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI studyBreast Cancer Research and Treatment, 2010
- Action of Modafinil—Increased Motivation Via the Dopamine Transporter Inhibition and D1 Receptors?Biological Psychiatry, 2010
- The effect of modafinil on cognitive function in breast cancer survivorsCancer, 2009
- A novel electrophysiological model of chemotherapy-induced cognitive impairments in miceNeuroscience, 2008
- Short‐term effects of treatment‐induced hormonal changes on cognitive function in breast cancer patientsCancer, 2008
- ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapyClinical Neurophysiology, 2008
- Cognitive function in breast cancer patients prior to adjuvant treatmentBreast Cancer Research and Treatment, 2007